Attached files
file | filename |
---|---|
EX-10.22 - EX-10.22 - Athira Pharma, Inc. | atha-ex1022_820.htm |
EX-10.21 - EX-10.21 - Athira Pharma, Inc. | atha-ex1021_821.htm |
EX-5.1 - EX-5.1 - Athira Pharma, Inc. | atha-ex51_751.htm |
EX-4.1 - EX-4.1 - Athira Pharma, Inc. | atha-ex41_478.htm |
S-1/A - S-1/A - Athira Pharma, Inc. | atha-s1a.htm |
Consent of Ernst and Young, LLP, Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” and to the use of our report dated July 24, 2020, except for Note 17(a), 17(g), 17(h) and 17(i), as to which the date is September 14, 2020, in Amendment No. 2 to the Registration Statement (Form S-1 333-248428) and related Prospectus of Athira Pharma, Inc. for the registration of its common stock.
/s/ Ernst & Young LLP
Seattle, Washington
September 14, 2020